AI-Enhanced Cardiovascular Ultrasound Launches With 4D Imaging Capabilities
The recently cleared system is designed with a new imaging architecture and AI-driven tools to enhance workflow efficiency and diagnostic speed.
The recently cleared system is designed with a new imaging architecture and AI-driven tools to enhance workflow efficiency and diagnostic speed.
The investigational system uses X-ray diffraction and AI to analyze the molecular composition of tissue, aiming to reduce unnecessary biopsies.
From artificial intelligence-assisted troubleshooting to predictive platforms, vendors and end-users share what’s working—and what it takes to get there.
The recently cleared system is designed with a new imaging architecture and AI-driven tools to enhance workflow efficiency and diagnostic speed.
The program offers mail-in calibration, scheduled reminders, and shipment tracking to help facilities maintain accurate survey meter performance and meet regulatory requirements.
The device combines ultrasound elastography with AI features to help clinicians assess liver fat and stiffness at the point of care for patients with chronic liver disease.
Effective stakeholder analysis and requirements gathering are critical to safe, compliant infusion system design.
The acquisition positions the company with a suite of AI-powered breast cancer image interpretation and workflow solutions.
The Rigel 288+ downloader app for iOS devices lets biomedical device engineers download and manage electrical safety test data.
The floor-mounted digital X-ray system automates in-room workflows and repetitive tasks to help improve throughput and reduce the technologist learning curve.
Designed to support particle therapies including proton and carbon ion, the system combines upright positioning with onboard CT imaging.
The multi-functional device enables both cutting and coagulation via flexible endoscopy and is now cleared for US clinical use.
Building on the success of Microsoft’s ambient listening tech for physicians, Tampa General is extending similar AI tools to nurses to reduce bedside documentation time.
New tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.